• Nenhum resultado encontrado

Nullity of GSTT1/GSTM1 related to pesticides is associatedwith Parkinson's disease

N/A
N/A
Protected

Academic year: 2017

Share "Nullity of GSTT1/GSTM1 related to pesticides is associatedwith Parkinson's disease"

Copied!
6
0
0

Texto

Loading

Imagem

Fig 2 shows the analysis of smoking, drinking and pesti- pesti-cide exposure data. SG had higher smokers prevalence  (43%) than CG (36%) — however not statistically relevant  (p=0.225)
Table 3. Distribution for patients with Parkinson disease in relation to glutathione S-transferases M1 and T1 polymorphisms,  considering drinking habit
Table 4. Distribution for patients with Parkinson disease in relation to glutathione S-transferases M1 and T1 polymorphisms,  considering previous contact with agrotoxic

Referências

Documentos relacionados

Сделаны выводы: распространенность БП в России, по данным сквозных исследований, на уровне показателей в западных странах; распространенность БП по обращаемости в 2–3

Perante esta hipótese e tendo em conta as evidências reportadas por Kinnman (2005), parece fundamental aprofundar este caminho de investigação, procurando os significados, as

 Em todas as referências apresentadas, a textura da taipa é utilizada na linguagem arquitetónica dos edifícios. Os arquitetos utilizam a plasticidade do material

The impaired excretion of copper re- sults in an increase in serum levels and accumulation of copper in the body.. Various clinical signs can be observed in the liver, nervous

Present meta-analysis showed that there was no significant association be- tween GSTT1 and GSTM1 null genotypes and hypertension risk.. It seems that GSTT1 and GSTM1

Based on the predicted penetrance and the frequencies, a variant in PLXNA4 proved to be the best candidate and PLXNA4 was screened for additional variants in 862 PD cases and

Patients with PD show impairments in many as- pects of postural control including: 1) rigidity afect- ing biomechanics, 2) bradykinesia of postural re- sponses and anticipatory

Healthy control with mixed affinity binder (HC-MAB) and Parkinson ’ s disease with MAB (PD-MAB) groups as well as healthy control with high affinity binder (HC-HAB) and Parkinson ’